Engage with AIBL: Data, Discovery and Collaboration for EMCRs

This informative and inspiring webinar explores the AIBL study - one of the world's leading longitudinal studies on Alzheimer's disease. Featured EMCR talks presented by: Dr Azadeh Feizpour - Senior Research Fellow at Austin Health Azadeh's work focuses on validating newly developed blood biomarkers for AD against established neuroimaging gold standards for AD diagnosis, using data from the AIBL and ADNeT studies, and working closely with clinical experts to implement novel diagnostic techniques. Dr Emily Rosenich - Alzheimer's Association Research Fellow at the Turner Institute for Brain and Mental Health, Monash University Emily's research investigates how cardiovascular, lifestyle, and genetic factors contribute to cognitive decline and dementia. Dr Eleanor O'Brien - Postdoctoral Research Fellow at Centre for Precision Health and School of Medical and Health Sciences, Edith Cowan University. Eleanor's work explores how genetic and environmental factors interact to influence AD risk and progression, drawing on AIBL and other longitudinal cohort studies to understand individual variability in disease trajectories.